These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25953731)

  • 1. Design of Fexofenadine Prodrugs Based on Tissue-Specific Esterase Activity and Their Dissimilar Recognition by P-Glycoprotein.
    Ohura K; Nakada Y; Kotani S; Imai T
    J Pharm Sci; 2015 Sep; 104(9):3076-83. PubMed ID: 25953731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a novel system for estimating human intestinal absorption using Caco-2 cells in the absence of esterase activity.
    Ohura K; Sakamoto H; Ninomiya S; Imai T
    Drug Metab Dispos; 2010 Feb; 38(2):323-31. PubMed ID: 19923255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intestinal first-pass hydrolysis on the oral bioavailability of an ester prodrug of fexofenadine.
    Ohura K; Soejima T; Nogata R; Adachi Y; Ninomiya S; Imai T
    J Pharm Sci; 2012 Sep; 101(9):3264-74. PubMed ID: 22628163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of the Oral Absorption of Ester-type Prodrugs].
    Ohura K
    Yakugaku Zasshi; 2020; 140(3):369-376. PubMed ID: 32115554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Carboxylesterase Isozymes and Their Role in the Behavior of a Fexofenadine Prodrug in Rat Skin.
    Imai T; Ariyoshi S; Ohura K; Sawada T; Nakada Y
    J Pharm Sci; 2016 Feb; 105(2):714-721. PubMed ID: 26444870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment and Characterization of a Novel Caco-2 Subclone with a Similar Low Expression Level of Human Carboxylesterase 1 to Human Small Intestine.
    Ohura K; Nishiyama H; Saco S; Kurokawa K; Imai T
    Drug Metab Dispos; 2016 Dec; 44(12):1890-1898. PubMed ID: 27638507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of P-glycoprotein on intestinal absorption and brain penetration of antiallergic agent bepotastine besilate.
    Ohashi R; Kamikozawa Y; Sugiura M; Fukuda H; Yabuuchi H; Tamai I
    Drug Metab Dispos; 2006 May; 34(5):793-9. PubMed ID: 16455807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of endogenous esterase activity on in vitro p-glycoprotein profiling of dabigatran etexilate in Caco-2 monolayers.
    Ishiguro N; Kishimoto W; Volz A; Ludwig-Schwellinger E; Ebner T; Schaefer O
    Drug Metab Dispos; 2014 Feb; 42(2):250-6. PubMed ID: 24212377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hydrolysis by carboxylesterase and disposition of prodrug with ester moiety].
    Imai T
    Yakugaku Zasshi; 2007 Apr; 127(4):611-9. PubMed ID: 17409690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of esterases expressed in Caco-2 cells and effects of their hydrolyzing activity in predicting human intestinal absorption.
    Imai T; Imoto M; Sakamoto H; Hashimoto M
    Drug Metab Dispos; 2005 Aug; 33(8):1185-90. PubMed ID: 15908471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of intestinal carboxylesterase in the oral absorption of prodrugs.
    Imai T; Ohura K
    Curr Drug Metab; 2010 Nov; 11(9):793-805. PubMed ID: 21189138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited influence of P-glycoprotein on small-intestinal absorption of cilostazol, a high absorptive permeability drug.
    Toyobuku H; Tamai I; Ueno K; Tsuji A
    J Pharm Sci; 2003 Nov; 92(11):2249-59. PubMed ID: 14603510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of steric hindrance and electron density of ester prodrugs on controlling the metabolic activation by human carboxylesterase.
    Takahashi M; Hirota I; Nakano T; Kotani T; Takani D; Shiratori K; Choi Y; Haba M; Hosokawa M
    Drug Metab Pharmacokinet; 2021 Jun; 38():100391. PubMed ID: 33872946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capsaicin pretreatment enhanced the bioavailability of fexofenadine in rats by P-glycoprotein modulation: in vitro, in situ and in vivo evaluation.
    Bedada SK; Appani R; Boga PK
    Drug Dev Ind Pharm; 2017 Jun; 43(6):932-938. PubMed ID: 28102715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and assessment of first-generation polyamidoamine dendrimer prodrugs to enhance the cellular permeability of P-gp substrates.
    Najlah M; Freeman S; Attwood D; D'Emanuele A
    Bioconjug Chem; 2007; 18(3):937-46. PubMed ID: 17355118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine.
    Cvetkovic M; Leake B; Fromm MF; Wilkinson GR; Kim RB
    Drug Metab Dispos; 1999 Aug; 27(8):866-71. PubMed ID: 10421612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arbaclofen placarbil, a novel R-baclofen prodrug: improved absorption, distribution, metabolism, and elimination properties compared with R-baclofen.
    Lal R; Sukbuntherng J; Tai EH; Upadhyay S; Yao F; Warren MS; Luo W; Bu L; Nguyen S; Zamora J; Peng G; Dias T; Bao Y; Ludwikow M; Phan T; Scheuerman RA; Yan H; Gao M; Wu QQ; Annamalai T; Raillard SP; Koller K; Gallop MA; Cundy KC
    J Pharmacol Exp Ther; 2009 Sep; 330(3):911-21. PubMed ID: 19502531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evasion of P-gp mediated cellular efflux and permeability enhancement of HIV-protease inhibitor saquinavir by prodrug modification.
    Jain R; Agarwal S; Majumdar S; Zhu X; Pal D; Mitra AK
    Int J Pharm; 2005 Oct; 303(1-2):8-19. PubMed ID: 16137847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human carboxylesterase isozymes: catalytic properties and rational drug design.
    Imai T
    Drug Metab Pharmacokinet; 2006 Jun; 21(3):173-85. PubMed ID: 16858120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biotransformation of prasugrel, a new thienopyridine prodrug, by the human carboxylesterases 1 and 2.
    Williams ET; Jones KO; Ponsler GD; Lowery SM; Perkins EJ; Wrighton SA; Ruterbories KJ; Kazui M; Farid NA
    Drug Metab Dispos; 2008 Jul; 36(7):1227-32. PubMed ID: 18372401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.